Infliximab Was Found to Be Effective for Treating Immunosuppressive Drug-resistant Hepatitis due to Durvalumab

A 69-year-old man with stage III lung squamous cell carcinoma developed immune-related hepatitis following treatment with durvalumab, and was given high-dose corticosteroids and immunosuppressive drugs (mycophenolate mofetil, azathioprine, tacrolimus) but without demonstrating any improvement. Two c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Intern Med
Main Authors: Nakashima, Koki, Demura, Yoshiki, Oi, Masahiro, Tabata, Mio, Tada, Toshihiko, Shiozaki, Kohei, Akai, Masaya, Ishizuka, Tamotsu
Format: Artigo
Jezik:Inglês
Izdano: The Japanese Society of Internal Medicine 2020
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7759708/
https://ncbi.nlm.nih.gov/pubmed/32727989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5216-20
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki